More women opted for sterilization after Roe was overturned
New research shows that the trend is especially high in states where abortion was banned

In the months since the Supreme Court overturned the constitutional protection of abortion access, many states have passed laws restricting or outright banning the procedure. New research suggests that women are increasingly turning to sterilization as a means of contraception, especially in states where abortions are banned.
Tubal ligations on the rise
A study published this month showed that more women were electing to have tubal ligations, colloquially known as getting your tubes tied, during the six months following the overturning of Roe v. Wade in June 2022. The research recently published in the Journal of the American Medical Association (JAMA) examined private insurance claims from 2021 and 2022 for around 4.8 million women across 36 states and Washington, D.C., who received the sterilization procedure. The surgery involves permanently closing the fallopian tubes so that the patient can no longer get pregnant.
The researchers categorized the states as "banned," "limited" or "protected," based on their abortion policies. In the 18 months before the Dobbs decision, the rate of tubal ligations remained steady in all three groups. However, in the six months after June 2022, the number of sterilization procedures for women increased in all three groups. The rise was "most pronounced in states that effectively banned abortion, where sterilizations rose 39% by December 2022," said The New York Times. During the period they studied, the number of tubal ligations rose by 3% every month in banned states. The results suggest that overturning Roe v. Wade affected not only abortion access but "decisions women are making about contraception as well," Xiao Xu, an associate professor of reproductive sciences at Columbia University and the study's lead author, said to the outlet.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The research letter is the latest study to find a rise in sterilization after the Supreme Court's decision. A study published in April in JAMA Health Forum found an abrupt spike in sterilization procedures among young adults aged 18 to 30. While the rate of both tubal libations and vasectomies increased rapidly, the rate of women getting their tubes tied was twice as high.
Proof of 'fear and anxiety around the ruling'
Jacqueline Ellison, an assistant professor at the University of Pittsburgh's School of Public Health and the lead author of the April study, said the findings illuminate essential questions about how people have responded to the ruling. The data suggests that people are "experiencing fear and anxiety around the ruling," she said to the Times, "either for their ability to get an abortion or even to access contraception in the future." She noted that the data from the latest study had limitations, as it did not look at federal and state-funded health insurance recipients or the uninsured. Women with private insurance "probably are not the population that is going to experience the worst consequences of Dobbs," Ellison said.
While the scope of the latest research letter is small, it is important to continue to study tubal ligations "because it is an irreversible method of contraception," Xiao Xu, the September study lead author, said to Gizmodo. There is the risk that some may regret their decision. And while it is considered a "very safe procedure," it is still a surgery and "has potential risks for surgical complications."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and cannabis industry news.
-
How does the Kennedy Center work?
The Explainer The D.C. institution has become a cultural touchstone. Why did Trump take over?
By Joel Mathis, The Week US Published
-
What are reciprocal tariffs?
The Explainer And will they fix America's trade deficit?
By Joel Mathis, The Week US Published
-
Leonard Peltier released from prison
Speed Read The Native American activist convicted of killing two FBI agents had his life sentence commuted by former President Joe Biden
By Rafi Schwartz, The Week US Published
-
Oysters could help combat antibiotic resistance
Under the radar The mollusk shows infection-fighting abilities
By Devika Rao, The Week US Published
-
Sperm cells can carry past trauma in their DNA
Under the radar Your parent's past may be affecting your future
By Devika Rao, The Week US Published
-
IVM is a better treatment than IVF for some women
The Explainer A less painful, less costly option for treating infertility emerges
By Theara Coleman, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
The decline of the contraceptive pill
In the Spotlight Fears of the pill's side effects, stoked by social media, behind switch to fertility trackers – or no contraception at all
By Harriet Marsden, The Week UK Published
-
Kidney stones are affecting children far more than they once did
Under the radar Salt may be to blame
By Devika Rao, The Week US Published
-
Naltrexone: the wonder drug for alcoholism
The pill is said to have a high success rate in reducing alcohol cravings with few side effects
By Richard Windsor, The Week UK Published
-
Drugmakers paid pharmacy benefit managers to avoid restricting opioid prescriptions
Under the radar The middlemen and gatekeepers of insurance coverage have been pocketing money in exchange for working with Big Pharma
By Theara Coleman, The Week US Published